Is CURE or NOBL a better dividend investment in 2026?

CURE currently yields 1.30% with a 5% 5-year dividend growth rate. NOBL yields 2.17% with 5% growth. The better choice depends on your goal: NOBL offers higher current income.

What is the dividend yield difference between CURE and NOBL?

CURE has a forward dividend yield of 1.30% ($1.19/share annually). NOBL yields 2.17% ($2.27/share annually). The yield gap is 0.87 percentage points.

Home › Compare › CURE vs NOBL

CURE vs NOBL: Dividend Comparison 2026

CURE yields 1.30% · NOBL yields 2.17%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NOBL wins by $1.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CURE

● Live price

1.30%

Share price

$91.57

Annual div

$1.19

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.5K

Annual income

$141.38

Full CURE calculator →

NOBL

● Live price

2.17%

Share price

$104.67

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.9K

Annual income

$249.78

Full NOBL calculator →

Portfolio growth — CURE vs NOBL

📍 NOBL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CURE	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CURE + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CURE pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CURE

Annual income on $10K today (after 15% tax)

$110.46/yr

After 10yr DRIP, annual income (after tax)

$120.17/yr

NOBL

Annual income on $10K today (after 15% tax)

$184.52/yr

After 10yr DRIP, annual income (after tax)

$212.31/yr

At 15% tax rate, NOBL beats the other by $92.14/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CURE + NOBL for your $10,000?

CURE: 50%NOBL: 50%

100% NOBL50/50100% CURE

Portfolio after 10yr

$22.2K

Annual income

$195.58/yr

Blended yield

0.88%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CURE buys

NOBL buys

No recent congressional trades found for CURE or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCURENOBL

Forward yield	1.30%	2.17% ✓
Annual dividend / share	$1.19	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$21.5K	$22.9K ✓
Annual income after 10y	$141.38	$249.78 ✓
Total dividends collected	$1.4K	$2.3K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CURE vs NOBL ($10,000, DRIP)

Year	CURE Portfolio	CURE Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$10,830	$129.96	$10,917	$217.08	$87.00 → NOBL
2	$11,720	$131.53	$11,903	$221.48	$183.00 → NOBL
3	$12,673	$133.03	$12,962	$225.68	$289.00 → NOBL
4	$13,695	$134.44	$14,099	$229.68	$404.00 → NOBL
5	$14,789	$135.77	$15,319	$233.49	$530.00 → NOBL
6	$15,961	$137.03	$16,628	$237.10	$667.00 → NOBL
7	$17,217	$138.22	$18,033	$240.53	$816.00 → NOBL
8	$18,561	$139.33	$19,539	$243.78	$978.00 → NOBL
9	$20,001	$140.39	$21,154	$246.86	$1.2K → NOBL
10	$21,542	$141.38	$22,884	$249.78	$1.3K → NOBL

CURE vs NOBL: Complete Analysis 2026

CURE — Stock

The Direxion Daily Healthcare Bull 3X Shares seeks daily investment results, before fees and expenses, of 300% of the performance of the Health Care Select Sector Index. There is no guarantee the fund will achieve its stated investment objectives.

Full CURE Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this CURE vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CURE vs SCHD CURE vs JEPI CURE vs O CURE vs KO CURE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.